# Executive Security Program Status Report

**Reporting Period:** April 2026  
**Program Owner:** Security TPM  
**Executive Sponsor:** CISO

## 1) Current Program Health
**Overall Status:** **Yellow (On Track with Managed Risks)**

- Roadmap execution is progressing with 80% of Phase 1 milestones delivered.
- Detection and reporting visibility improved; remediation throughput remains the primary constraint.
- Governance artifacts are in place and monthly operating cadence is stable.

## 2) Completed Milestones (This Period)
- Centralized GuardDuty ingestion and severity mapping completed.
- Weekly OpenVAS reporting with critical aging segment launched.
- Security control inventory ownership baseline established.
- Initial KPI dashboard (MTTD, alert volume, vuln aging) published.

## 3) Risks and Blockers
1. **Delayed remediation on critical vulnerabilities** (High impact)  
   - Blocker: Limited engineering capacity on two platform teams.
2. **Asset inventory completeness gap** (Critical impact)  
   - Blocker: Inconsistent tagging for legacy cloud workloads.
3. **Potential alert fatigue during ingestion expansion** (High impact)  
   - Blocker: Tuning backlog exceeds current analyst bandwidth.

## 4) Decisions Needed
1. Approve temporary remediation sprint allocation from Platform Team B (Owner: CTO, Due: May 10, 2026).
2. Endorse mandatory asset tagging policy enforcement in CI/CD (Owner: CIO, Due: May 15, 2026).
3. Confirm headcount backfill for SecOps analyst capacity (Owner: CISO, Due: May 20, 2026).

## 5) Next 30/60/90 Day Priorities

### Next 30 Days
- Finalize automated escalation for High/Critical alerts.
- Publish remediation SLA scorecard by team.
- Complete asset inventory reconciliation plan.

### Next 60 Days
- Deploy incident prioritization engine v1.
- Launch risk-based vulnerability remediation queue.
- Stand up monthly control failure review forum.

### Next 90 Days
- Deliver control-as-code pilot for top 20 controls.
- Release executive risk trend report with quarter-over-quarter comparison.
- Re-baseline roadmap for Phase 2/3 based on delivery capacity and risk signals.
